Correlation between Transformation Trigger Ranking, Operational Evidence, and Expert Opinion Survey
| Pharmaceutical Transformation Triggers | Transformation Trigger and Survey Question Mapping | Theoretical Evidence Strength (Importance Ranking)* | Operational Evidence Strength | Cumulative Question Means | Sum of Participant Comments |
|---|---|---|---|---|---|
| 1. Healthcare Management–Focused | 8, 22 | 6 | 90 | 107.58 | 7 |
| 2. Fully Integrated Pharma Network | 8, 9, 10, 18 | 3 | 80 | 249.12 | 9 |
| 3. Personalized Medicine | 8, 9, 10, 11,13, 22, 24 | 1 | 100 | 383.96 | 19 |
| 4. Virtual R&D | 8 | 11 | 45 | 38.64 | 3 |
| 5. Translational Research | 8, 17 | 4 | 60 | 98.48 | 6 |
| 6. Adaptive/In-life Trials | 12 | 50 | 0 | 0 | |
| 7. Global Harmonization | 7, 17 | 9 | 50 | 115.40 | 5 |
| 8. Science & Risk-Based Regulations | 15, 16, 17 | 7 | 55 | 189.02 | 8 |
| 9. Live Licensing | 13 | 0 | 0 | 0 | |
| 10. Enforcement | 17 | 14 | 55 | 59.85 | 3 |
| 11. Biotechnology | 8, 13, 24 | 8 | 60 | 139.77 | 7 |
| 12. Nanotechnology | 10 | 50 | 0 | 0 | |
| 13. Bioinformatics | 5 | 65 | 0 | 0 | |
| 14. Pervasive/Cloud Computing | 8, 9, 12, 14, 29 | 2 | 70 | 279.12 | 10 |
↵* Results from earlier part of our research (2, 3).